tert-Butyl 2-formyl-4h,5h,6h,7h-thieno[3,2-c]pyridine-5-carboxylate, 95+%, 5g

Ethyl 3-bromo-2-oxocyclohexanecarboxylate, 95%, 10g

((2R,3R,4R,5R)-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate, 98%, 100mg

3-(2,3,4-Trimethoxyphenyl)propanoic acid, 95.0%, 1g

DBCO-?C6-?acid, 97.02%, 1g

10-Phenyl-9(10H)-acridone>98.0%(HPLC)1g

4-Methoxy-3-nitrobenzotrifluoride, 98.0%, 1g

(R)-2-(Aminomethyl)-4-methylpentanoic acid hydrochloride, 95.0%, 250mg

8-Bromo-6-fluorochroman, 95.0%, 250mg

(6-Morpholinopyridazin-3-yl)methanamine hydrochloride, 95.0%, 50mg

((4-(Bromomethyl)phenyl)sulfonyl)(4-methylthiophenyl)amine, 97%, 1g

tert-Butyl 2-Hydroxyethyl(methyl)carbamate, 97.0%, 1kg

Ethyl 4-Oxo-3-piperidinecarboxylate Hydrochloride>98.0%(HPLC)(N)25g